← Leaderboards
Eugene A Konorev
University Of Hawaii At Manoa
$941,840
Attributed
$941,840
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $464.4K · FY2011–23$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$941,840 · 3
By mechanism
R15$872,984 · 2
P20$68,856 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Hawaii At Manoa
Same institution · by research overlap
- Andrew Kekupa'a Knutson$333,052
- Janet M Burlingame$508,003
- Ka'imi Alohilani Sinclair$8,782,672
Others in their field
Top investigators on “Heart”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S Hochman · New York University School Of Medicine$118,439,174
- Deborah Nickerson · University Of Washington$86,844,068
- Rebecca Montalvan · Westat, Inc.$86,600,000
Research focus
HeartDoxorubicinDesignCardiacEndothelial CellsStudentsResearch StudyTissuesMortalityAnimalsPreventProductionBlood VesselsResponsePathway InteractionsCardiovascular SystemAngiogenesisCell TypeGene ExpressionPrevalenceIn VitroIn VivoCardiomyopathiesTransforming Growth Factor Beta
Grant awards (3)
Endothelial Smad3 as a Novel Target to Avert Chemotherapy Induced Cardiomyopathy$408,599
R15 · FY2023 · HL · contact PI
Endothelial Smad3 as a novel target for enhancing angiogenesis in the failing heart$464,385
R15 · FY2016 · HL · contact PI
ANGIOGENIC ACTION OF NATURAL PRODUCTS$68,856
P20 · FY2011 · RR · contact PI